<DOC>
	<DOCNO>NCT02628626</DOCNO>
	<brief_summary>Fecal incontinence ( FI ) common symptom significantly impair quality life . There limited , mostly uncontrolled , evidence support approach currently use manage FI . The alpha-2 adrenergic agonist clonidine decrease frequency loose stool FI patient diarrhea . Among patient diarrhea , clonidine decrease proportion day FI ; however result statistically significant . Uncontrolled study suggest bile acid bind resin colesevelam also increase stool consistency patient functional diarrhea . In study , investigator propose compare effect combination colesevelam clonidine placebo bowel symptom patient urge combine type FI . The investigator hypothesis combination treatment clonidine colesevelam well placebo reduce stool frequency rectal urgency FI .</brief_summary>
	<brief_title>A Study Colesevelam Fecal Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Fecal Incontinence</mesh_term>
	<mesh_term>Malabsorption Syndromes</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>A . Phase 1 ) Females age 1880 year urge predominant combine ( i.e . urge plus passive ) FI , define validated questionnaire , least 1 year duration eligible participate . ( ) History clinically serious cardiovascular pulmonary disease EKG show 2nd degree atrioventricular block high . ( ii ) Current past history rectal cancer , scleroderma , inflammatory bowel disease , small bowel obstruction , congenital anorectal abnormality , Grade 2 rectal prolapse , history rectal resection pelvic irradiation ( iii ) Neurological disorder Spinal cord injury , dementia ( MiniMental status score &lt; 21 ) , multiple sclerosis , Parkinson 's disease , peripheral neuropathy ( iv ) Conditions preclude safe use clonidine , i.e. , symptomatic hypotension , systolic blood pressure &lt; 100 mm Hg initial visit Phase 1 study ( v ) Currently pregnant nursing woman ( vi ) Prior history intolerance clonidine colesevelam ( vii ) Medications Absolute opioid analgesic . Relative antihypertensive agent ( i.e . concern synergistic effect hypotension ) . Patients use drug anticholinergic effect exclude use high dos ( e.g . nortriptyline great 50 mg/day amitriptyline great 25 mg/day ) . Patients use low dos eligible participate provide dose stable study B . Phase 2 ) Females age 1880 year urge predominant combine ( i.e . urge plus passive ) FI least 1 year , define questionnaire Exclusion criterion : ( ) Positive urine pregnancy screen C. Phase 3 Inclusion criterion : ( ) Completion least 5 7 day diary precede week 10 14 precede 2 week ( ii ) At least 1 episode FI per week average 2 week ( iii ) Average Bristol stool score 3 high ( iv ) Average stool frequency â‰¥1/day Exclusion criterion ( least one satisfy ) : ( ) Missing data bowel diary , i.e . patient record bowel symptom data 2 day 1 week 4 day 2 week ( ii ) Greater 6 liquid [ Bristol 6 7 ] ) stool daily ( iii ) Average le 1 bowel movement daily ( iv ) Average Bristol stool score &lt; 3 assessed analysis bowel diary D. Phase 4 Inclusion criterion : ( ) All patient complete least 1 week treatment study drug placebo Exclusion criterion : ( ) Patients complete less 1 week treatment study drug placebo</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Incontinence</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Bile acid</keyword>
	<keyword>Microbiome</keyword>
</DOC>